Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

The Inceptiv spinal cord stimulation system. [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord ...

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Kuros Biosciences USA entered into a five-year exclusive sales agency agreement with Medtronic spinal division.

Kuros Biosciences products include MagnetOs Putty ... The new five-year agreement provides Medtronic with exclusivity in certain spine geographies within the U.S. market. According to Kuros ...

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at ...

What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission, Martha, Chairman and CEO at Medtronic, executed a strategic derivative sale. This involved ...